484 related articles for article (PubMed ID: 36029799)
21. Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study.
Autier B; Prattes J; White PL; Valerio M; Machado M; Price J; Egger M; Gangneux JP; Hoenigl M
J Clin Microbiol; 2022 Jan; 60(1):e0168921. PubMed ID: 34643415
[TBL] [Abstract][Full Text] [Related]
22. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.
Verweij PE; Brüggemann RJM; Azoulay E; Bassetti M; Blot S; Buil JB; Calandra T; Chiller T; Clancy CJ; Cornely OA; Depuydt P; Koehler P; Lagrou K; de Lange D; Lass-Flörl C; Lewis RE; Lortholary O; Liu PL; Maertens J; Nguyen MH; Patterson TF; Rijnders BJA; Rodriguez A; Rogers TR; Schouten JA; Wauters J; van de Veerdonk FL; Martin-Loeches I
Intensive Care Med; 2021 Aug; 47(8):819-834. PubMed ID: 34160631
[TBL] [Abstract][Full Text] [Related]
23. Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study.
Kim SH; Hong JY; Bae S; Lee H; Wi YM; Ko JH; Kim B; Joo EJ; Seok H; Shi HJ; Yoo JR; Hyun M; Kim HA; Jang S; Mun SJ; Kim J; Kim MC; Jung DS; Kim SH; Peck KR
J Korean Med Sci; 2022 May; 37(18):e134. PubMed ID: 35535369
[TBL] [Abstract][Full Text] [Related]
24. Invasive pulmonary aspergillosis associated with viral pneumonitis.
Dewi IM; Janssen NA; Rosati D; Bruno M; Netea MG; Brüggemann RJ; Verweij PE; van de Veerdonk FL
Curr Opin Microbiol; 2021 Aug; 62():21-27. PubMed ID: 34034082
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics and outcomes of influenza-associated pulmonary aspergillosis among critically ill patients: a systematic review and meta-analysis.
Chong WH; Saha BK; Tan CK
J Hosp Infect; 2022 Feb; 120():98-109. PubMed ID: 34843812
[TBL] [Abstract][Full Text] [Related]
26. Invasive Tracheobronchial Aspergillosis in Critically Ill Patients with Severe Influenza. A Clinical Trial.
Nyga R; Maizel J; Nseir S; Chouaki T; Milic I; Roger PA; Van Grunderbeeck N; Lemyze M; Totet A; Castelain S; Slama M; Dupont H; Sendid B; Zogheib E
Am J Respir Crit Care Med; 2020 Sep; 202(5):708-716. PubMed ID: 32407157
[No Abstract] [Full Text] [Related]
27. A Tale of Two Hospitals: Comparing CAPA Infections in Two ICUs During the Spanish Fourth Pandemic Wave.
Sánchez-Castellano MÁ; Marcelo C; Marco J; Figueira-Iglesias JC; García-Rodríguez J
Mycopathologia; 2023 Aug; 188(4):335-344. PubMed ID: 37256502
[TBL] [Abstract][Full Text] [Related]
28. COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
Erami M; Hashemi SJ; Raiesi O; Fattahi M; Getso MI; Momen-Heravi M; Daie Ghazvini R; Khodavaisy S; Parviz S; Mehri N; Babaei M
Infection; 2023 Feb; 51(1):223-230. PubMed ID: 36107379
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a
Giacobbe DR; Prattes J; Wauters J; Dettori S; Signori A; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Klimko N; Shadrivova O; Cornely OA; Rautemaa-Richardson R; Koehler P; Lagrou K; Bassetti M; Hoenigl M;
J Clin Microbiol; 2022 Apr; 60(4):e0229821. PubMed ID: 35321555
[TBL] [Abstract][Full Text] [Related]
30. Profiling Bacteria in the Lungs of Patients with Severe Influenza Versus COVID-19 with or without Aspergillosis.
Feys S; Cardinali-Benigni M; Lauwers HM; Jacobs C; Stevaert A; Gonçalves SM; Cunha C; Debaveye Y; Hermans G; Heylen J; Humblet-Baron S; Lagrou K; Maessen L; Meersseman P; Peetermans M; Redondo-Rios A; Seldeslachts L; Starick MR; Thevissen K; Vande Velde G; Vandenbriele C; Vanderbeke L; Wilmer A; Naesens L; van de Veerdonk FL; Van Weyenbergh J; Gabaldón T; Wauters J; Carvalho A
Am J Respir Crit Care Med; 2024 Jun; ():. PubMed ID: 38865563
[TBL] [Abstract][Full Text] [Related]
31. Development of a Corticosteroid-Immunosuppressed Mouse Model to Study the Pathogenesis and Therapy of Influenza-Associated Pulmonary Aspergillosis.
Wurster S; Pantaleón García J; Albert ND; Jiang Y; Bhoda K; Kulkarni VV; Wang Y; Walsh TJ; Evans S; Kontoyiannis DP
J Infect Dis; 2023 Apr; 227(7):901-906. PubMed ID: 36611269
[TBL] [Abstract][Full Text] [Related]
32. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.
Machado M; Valerio M; Álvarez-Uría A; Olmedo M; Veintimilla C; Padilla B; De la Villa S; Guinea J; Escribano P; Ruiz-Serrano MJ; Reigadas E; Alonso R; Guerrero JE; Hortal J; Bouza E; Muñoz P;
Mycoses; 2021 Feb; 64(2):132-143. PubMed ID: 33210776
[TBL] [Abstract][Full Text] [Related]
33. Genomic and Phenotypic Analysis of COVID-19-Associated Pulmonary Aspergillosis Isolates of Aspergillus fumigatus.
Steenwyk JL; Mead ME; de Castro PA; Valero C; Damasio A; Dos Santos RAC; Labella AL; Li Y; Knowles SL; Raja HA; Oberlies NH; Zhou X; Cornely OA; Fuchs F; Koehler P; Goldman GH; Rokas A
Microbiol Spectr; 2021 Sep; 9(1):e0001021. PubMed ID: 34106569
[TBL] [Abstract][Full Text] [Related]
34. A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA).
Feys S; Almyroudi MP; Braspenning R; Lagrou K; Spriet I; Dimopoulos G; Wauters J
J Fungi (Basel); 2021 Dec; 7(12):. PubMed ID: 34947049
[TBL] [Abstract][Full Text] [Related]
35. Point-of-care testing for viral-associated pulmonary aspergillosis.
Aerts R; Autier B; Gornicec M; Prattes J; Lagrou K; Gangneux JP; Hoenigl M
Expert Rev Mol Diagn; 2024 Mar; 24(3):231-243. PubMed ID: 37688631
[TBL] [Abstract][Full Text] [Related]
36. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.
Gangneux JP; Dannaoui E; Fekkar A; Luyt CE; Botterel F; De Prost N; Tadié JM; Reizine F; Houzé S; Timsit JF; Iriart X; Riu-Poulenc B; Sendid B; Nseir S; Persat F; Wallet F; Le Pape P; Canet E; Novara A; Manai M; Cateau E; Thille AW; Brun S; Cohen Y; Alanio A; Mégarbane B; Cornet M; Terzi N; Lamhaut L; Sabourin E; Desoubeaux G; Ehrmann S; Hennequin C; Voiriot G; Nevez G; Aubron C; Letscher-Bru V; Meziani F; Blaize M; Mayaux J; Monsel A; Boquel F; Robert-Gangneux F; Le Tulzo Y; Seguin P; Guegan H; Autier B; Lesouhaitier M; Pelletier R; Belaz S; Bonnal C; Berry A; Leroy J; François N; Richard JC; Paulus S; Argaud L; Dupont D; Menotti J; Morio F; Soulié M; Schwebel C; Garnaud C; Guitard J; Le Gal S; Quinio D; Morcet J; Laviolle B; Zahar JR; Bougnoux ME
Lancet Respir Med; 2022 Feb; 10(2):180-190. PubMed ID: 34843666
[TBL] [Abstract][Full Text] [Related]
37. Prevalence, Risk Factors, Clinical Features, and Outcome of Influenza-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Systematic Review and Meta-Analysis.
Lu LY; Lee HM; Burke A; Li Bassi G; Torres A; Fraser JF; Fanning JP
Chest; 2024 Mar; 165(3):540-558. PubMed ID: 37742914
[TBL] [Abstract][Full Text] [Related]
38. Integrating genetic and immune factors to uncover pathogenetic mechanisms of viral-associated pulmonary aspergillosis.
Gonçalves SM; Pereira I; Feys S; Cunha C; Chamilos G; Hoenigl M; Wauters J; van de Veerdonk FL; Carvalho A
mBio; 2024 Jun; 15(6):e0198223. PubMed ID: 38651925
[TBL] [Abstract][Full Text] [Related]
39. COVID-19-associated pulmonary aspergillosis is associated with increased in-hospital mortality and prolonged SARS-CoV-2 viral shedding.
Huang JR; Shen HC; Sun CY; Chen WC; Chen YM; Feng JY; Yang KY
J Formos Med Assoc; 2022 Dec; 121(12):2617-2625. PubMed ID: 35953342
[TBL] [Abstract][Full Text] [Related]
40. COVID-19-associated pulmonary aspergillosis (CAPA): identification of Aspergillus species and determination of antifungal susceptibility profiles.
Ozturk A; Bozok T; Erdogan M; Ibrahim BM; Bozok TS
Folia Microbiol (Praha); 2023 Dec; 68(6):951-959. PubMed ID: 37294497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
